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Abstract. The well-established SMART test, a somatic mutation and recombination assay of 
Drosophila, was applied to assess the possible genotoxicity ofsublethal meta-tetra(hydroxyphenyl) 
chlorin (mTHPC) photodynamic therapy (PDT) to clonogenic ells in situ. The SMART assay 
monitors the loss of heterozygosity (LOH) at selected cell-marker loci in clonogenic ells of the 
larval wing primordia. No evidence of genotoxicity was observed under conditions that killed 
between 38 and 86% of the exposed test larvae. Since the SMART assay is based on the oral uptake 
of the suspected genotoxic agent, the uptake kinetics of mTHPC by the assay's pecific target cells 
must be known. Therefore, relevant studies are being carried out at present in order to draw final 
conclusions from this negative test result for genotoxicity. 
INTRODUCTION 
Photodynamic tumour therapy (PDT) is based 
on the light-induced activation of photo- 
reactive drugs, thus generating highly reactive 
oxygen species that are toxic to the cells. Local 
restriction of photodynamic mpacts to the 
target issue is achieved by systemic or local 
administration of the photodynamic agents 
and, subsequently, strictly limited illumi- 
nation of the target issue area. The develop- 
ment of new photosensitizers i  regularly 
followed by extended preclinical studies. Such 
studies are now being carried out on the bio- 
reactivity of second-generation photosensi- 
tizers. Extensive testing of chlorins such as 
meta-tetra(hydroxyphenyl) chlorin (mTHPC) 
by in vitro experiments that analysed the dark 
toxicity and the DNA modifications of tumour 
cells found neither of these effects (1). The 
authors were also interested in the potential 
risk of genotoxicity and somatic mutagenicity 
of photosensitizers. In PDT, light scattering 
will inevitably leave a marginal zone of 
subcytotoxically treated cells. These could 
potentially constitute a source of late compli- 
cations arising from DNA alterations where 
the cell impact was sublethal. Activated oxy- 
gen, referred to as singlet oxygen, is a DNA- 
damaging agent (2). Its relatively short lifetime 
in solution, between micro- and milliseconds 
(3), limits its interaction with biomolecules to
the vicinity of the photoreagents from which it 
is produced. The risks of mutagenic effects 
from PDT will depend largely on the spatial 
distribution of photoreactive agents within 
the cytoplasmic and nuclear compartments of 
the cells (3 5). Several studies have actually 
demonstrated the DNA-modifying activity of 
photo-oxidative reactions. Following photo- 
oxidation by haematoporphyrin derivatives, 
DNA alterations such as alkali-labile sites (6), 
single- and double-strand breaks (7-10), induc- 
tion of sister chromatid exchanges (SCE) 
(11, 12) and chromosome aberrations were 
observed (13). Most interestingly, the inhi- 
bition of DNA repair functions by photo- 
oxidative reactions has also been documented 
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recently (10, 14). Consequently, mutagenic and 
clastogenic effects in subcytotoxically affected 
cells could also be produced indirectly as a 
consequence of an impaired capacity of the 
metabolism to maintain DNA integrity (10). 
For the present study of the genotoxicity 
of mTHPC and its photo-oxidative reaction, 
the well-established and sensitive somatic 
mutation and recombination assay of 
Drosophila melanogaster known as SMART 
was chosen (15-17). This test monitors the 
consequences of the loss of heterozygosity 
(LOH) due to a broad spectrum of mutational 
events such as point mutations, deletions, 
homologue recombination, chromosome loss 
and non-disjunction as well as gene conversion 
(15). Loss of heterozygosity is recognized as an 
important cause of tumour-suppressor neo- 
plasia mediated by gene loss in humans (16). In 
the fruit fly D. melanogaster, which is hetero- 
zygous for appropriate recessive mutations 
that alter the morphology of the cuticle in a 
cell-autonomous fashion, the loss of hetero- 
zygosity in somatic cell lineages becomes 
visible as spots of mutant characters (genetic 
mosaics) on the body surface of the adult flies. 
The authors addressed the question as to 
whether a subcytotoxic PDT treatment with 
mTHPC that killed 38-86% of the larvae would 
yield an enhanced frequency of LOH-mediated 
genetic mosaics among the survivors compared 
to untreated controls. 
MATERIALS AND METHODS 
The SMART test protocol has been described 
comprehensively b Graf et al (15). The test is 
based on feeding potential mutagens to larvae 
of the fruit fly D. melanogaster that are 
transheterozygous for the recessive wing-cell 
marker mutations multiple wing hairs (mwh) 
and flare (fir). The induced loss of hetero- 
zygosity at either or both of the loci in clono- 
genic cells is expressed in the resulting clones 
as mutant spots on the phenotypically wild- 
type wing surface of the hatched adults. 
Homologous recombination proximal to the 
marker loci gives rise to mwh/flr twin spots 
(Fig. 1). Single spots expressing the distal 
marker mwh result primarily from the recom- 
bination between the two marker positions 
mwh and fir, from terminal deletions covering 
the distal marker mwh or from mutation of the 
wild-type allele. Single spots expressing the 
phenotype of the proximal marker fir can 
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Fig. 1. Microscopic view of a wing area from a SMART 
assay fly displaying representative examples of clonal 
expression of the recessive cell-marker mutations multiple 
wing hairs (mwh) and flare (fir) following loss of 
heterozygosity (LOH) in wing precursor cells of a fly 
heterozygous at the r spective loci. 
result from double recombination proximal 
and distal to the respective locus fir, lethality 
of one of the twin products of a proximal 
recombination event, gene mutation or gene 
conversion (15). 
F 1 larvae from crosses of the homozygous 
mwh/mwh strain carrying the visible recessive 
mutation multiple wing hairs (mwh 3~).00) and 
of the balanced strain flr3/TM3, ri pp e bx34 
Ser, carrying the wing-hair mutation flare 
(fir 3-38.8) (15) were chronically exposed to 
the photosensitizer mTHPC (Foscan ~, Scotia 
Pharmaceuticals Ltd, Guildford, UK) by being 
fed up to 45 mg mTHPC per ml of instant food. 
After an incubation period of 64 h (84 h after 
egg laying), the larvae were exposed to laser 
illumination at 652 nm 8.45 J cm- 2 for 16 min. 
The irradiation was carried out using either an 
argon ion-pumped ye laser (Coherent Innova 
310 and CR 599, GMP, Switzerland) or a diode 
laser (Applied Optronics, USA). The lethality 
rate of the larvae in several test tubes pooled 
for this study was between 38 and 86%. 
The lethality rate was recorded 24-48 h after 
exposure to the laser illumination when 
the surviving larvae underwent pupation. In 
additional series, the larvae were exposed to 
Ringer solvent alone, to laser illumination 
alone, to mTHPC incubation in the dark and to 
4 Gy of X-rays (84 h after egg laying, 100 kVp 
X-rays, 1.4 Gy rain-1). In the last three series 
mentioned above, the survival of the larvae 
was not affected compared to the series subject 
to exposure to Ringer's solvent alone. X-rays 
of 4Gy were applied to demonstrate the 
operation of the assay. The X-ray dose was 
monitored by a PTW-SN4 dosimeter. After 
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metamorphosis, the hatched adults were 
collected and the wings were examined for 
mutant spots at a magnification of 400 x 
following the method and criteria of Graf et al 
(15). 
The statistical validation of the data 
obtained in this study was based on the 
computer-assisted program LIMIT for the 
routine evaluation of the Drosophila wing-spot 
test SMART (17). This program validates the 
mosaic frequency in control and treated 
series with respect o a null hypothesis H(O) 
postulating no difference between a control 
and a treated series, and the alternative 
hypothesis H(A) that assumes an a priori 
mosaic frequency m times the spontaneous 
level. Acceptance or rejection of either hypoth- 
esis is based on the conditional binomial 
distribution. 
RESULTS 
Figure 1 illustrates representative examples of 
clonal expressions in the wing margin of the 
recessive cell-marker mutations multiple wing 
hairs (mwh) and flare (fir) following radiation- 
induced LOH in the wing precursor cells of the 
larvae. Table I summarizes the total number of 
wings analysed and the scores of mosaic spots 
per wing in control and treated series, as 
well as the diagnosis for genotoxicity accord- 
ing to the LIMIT statistics program of the 
SMART genotoxicity assay (16). The particu- 
larly relevant clone classes are the large 
mwh single spots identifying LOH due primar- 
ily to distal mitotic recombination, terminal 
deletions and gene mutations, and the wmh/flr 
twin spots identifying the homologous recom- 
bination proximal to the marker loci. Small 
single spots result from LOH in development 
later than 84 h after egg laying (20). No effects 
on their frequency could be expected under 
the present treatment conditions. Single 
fir spots result from double recombination 
proximal and distal to this marker gene. Their 
spontaneous frequency is therefore very low 
(18) and will be affected only by strong 
recombinogenic agents. It is evident from the 
data compiled in Table 1 that the SMART 
assay is sensitive nough to detect he somatic 
mutagenicity and recombinogenicity associ- 
ated with a moderate X-ray dose of 4 Gy and, 
according to the authors' previous study (19), 
even with X-ray doses as low as I cGy. Con- 
versely, neither of the other treatments, 
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eg laser illumination alone, mTHPC dark 
toxicity or PDT treatment (mTHPC+laser), 
led to a recognizable enhancement of spot 
frequencies. H(0) was accepted at a signifi- 
cance level of 2a=0.05 in all these latter series 
and with respect o all indicators. 
DISCUSSION 
The biological effects of PDT are complex and 
their comprehensive elucidation requires 
diverse systematic studies. Every photosensi- 
tizer reacts differently and its targets are 
mainly subcellular organelles within the cyto- 
plasm. To establish PDT effects in greater 
detail, the dark toxicity and reactivity of 
mTHPC in vitro in human tumour cells was 
studied using two test systems, namely the 
colony-forming test and the cell-viability test 
(21, 22). These tests clearly demonstrated the 
effectiveness of mTHPC as a somatic photo- 
sensitizing substance. The decision to test the 
genotoxicity of PDT with a relevant assay was 
a logical consequence of the earlier analysis. 
The Drosophila SMART assay is well estab- 
lished in terms of toxicology and cross exami- 
nations of the effectiveness of drugs in the 
SMART test, and other established tests for 
carcinogenicity reveal an excellent correlation 
(23). The presented ata yielded no evidence 
of a genotoxic effect from PDT treatment 
mediated by mTHPC. Considering that the 
PDT treatment caused substantial ethality 
among the exposed larvae (38-86%), the possi- 
bility of insufficient uptake of mTHPC by the 
larvae can be excluded. However, the time- 
dependent and spatial pharmacokinetics of 
mTHPC has not yet been studied in the specific 
target tissue of the SMART assay. This study 
is currently in progress and its outcome is 
needed to draw final conclusions about the 
non-genotoxicity of PDT mediated by mTHPC 
in the SMART assay. A fluorescence analysis 
of the mTHPC uptake is being used in addition 
to cell pathology methods to identify necrotic 
and/or apoptotic cell decay after PDT treat- 
ment. Since the SMART assay has proved itself 
capable of identifying the genotoxic activity of 
a large variety of agents via oral application 
(23), the authors' preliminary inclination is to 
suggest hat the failure to observe genotoxic 
activity following the reported mTHPC 
PDT treatment is not merely a consequence 
of an insufficient uptake. On the basis of 
these results, the authors are optimistic that 
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D. melanogaster has the potential for being 
used in additional preclinical studies in PDT. 
Since various forms of malignant umour also 
occur in this insect that is so convenient o 
study, the authors have started a series of 
experiments to investigate the action of PDT 
on neoplasms using this model. 
ACKNOWLEDGEMENTS 
The authors thank Diana Dobler-Girdziunaite, Brigitte 
Jentsch and Ritva Haider for their excellent echnical 
help, and Pam Kessler and Richard Michel for assistance 
in preparing the manuscript. The authors also acknowl- 
edge Dr H. Frei of the Institute of Toxicology at the Swiss 
Federal Institute of Technology and the University of 
Ziirich for his support in applying the SMART statistical 
method. 
REFERENCES 
1 Hornung R, Jentsch B, Crompton NEA, Haller U, 
Walt H. In vitro effects and localisation of the photo- 
sensitizers m-THPC and m-THPC MD on carcinoma 
cells of the human breast (MCF-7) and Chinese hamster 
fibroblasts (V-79). Lasers Surg Med 1997, 20:443-50 
2 Decuyper-Debergh D, Piette J, Van deVorst A. Singlet 
oxygen-induced mutations in M3 lacZ phage DNA. 
EMBO J 1987, 6:3155~1 
3 Merkel PB, Kearns DR. Radiationless decay of singlet 
molecular oxygen in solution. An experimental nd 
theoretical study of electronic and vibrational energy 
transfer. J Am Chem Soc 1972, 94:7244-53 
4 deMol HJ, Beijersbergen GMJ, Mohn GR, Glickman 
BW, van Kleef PM. On the involvement of singlet 
oxygen in mutation induction by methoxypsoralen and 
UVA irradiation in E. coli. Murat Res 1981, 82:23-30 
5 Devasagayan TPA, Steenken S, ObendorfWSW, Schulz 
WA, Sies H. Formation of 8-hydroxy(deoxy)guanosin 
and generation of strand breaks at the guanine residue 
by singlet oxygen. Biochemistry 1991, 36:6282 9 
6 Gomer CJ. DNA damage and repair in CHO cells 
following haematoporphyrin photoradiation. Cancer 
Lett 1980, 11:161-7 
7 Moan J, Waksvik H, Christensen T. DNA single-strand 
breaks and sister chromatide xchanges induced by 
treatment with haematoporphyrin a d light or by 
X-rays in human NHiK3025 cells. Cancer Res 1980, 
40:2915-8 
8 Fiel RJ, Datta-Gupta N, Mark EH, Howard JC. Induc- 
tion of DNA damage by porphyrin photosensitization. 
Cancer Res 1981, 41:3543-5 
9 Epe B, Pflaum M, Boiteux S. DNA damage induced by 
photosensitizers in cellular and cell-free systems. Mutat 
Res 1993, 299:135-45 
10 Penning LC, Lagerberg JWM, VanDierendonck, 
Cornelisse CJ, Dubbelman TMAR, VanStevenick J.
P.M. Schweizer, H. Walt, M. Fehr, U. Hailer 
The role of DNA damage and inhibition of poly(ADP- 
ribosyl)ation in loss of clonogenicity of murine 
L-fibroblasts, caused by photodynamically induced 
oxydative stress. Cancer Res 1994, 54:5557~1 
11 Christensen T, Moan J, McGhie JB, Waksvik H, 
Stigum H. Studies of HpD chemical composition and in 
vitro photosensitization. I : Kessel D, Dougherty TJ 
(eds) Porphyrin Workshop. New York: Plenum, 
1983:151-64 
12 Gomer CJ, Rucker N, Banerjee A, Benedict WF. Com- 
parison of mutagenicity and induction of sister chroma- 
tid exchange in Chinese hamster cells exposed to 
hematoporphyrin derivative, photoradiation, ionizing 
radiation, or ultraviolet radiation. Cancer Res 1983, 
43:262~7 
13 Evensen JF, Moan J. Photodynamic action and chro- 
mosomal damage: A comparison of hematoporphyrin 
derivative (HpD) and light with X-irradiation. Br J 
Cancer 1982, 45:465 82 
14 Boegheim JPJ, Dubbelman TMAR, Mullerdens LHF. 
Photodynamic effects of heamtoporphyrin derivative 
on DNA repair in murine 1929-fibroblasts. Biochem J 
1987, 244:711-5 
15 Graf U, Wfirgler FE, Katz AJ, Frei H, Juon H, Hall CB, 
Kale PG. Somatic mutation- and recombination-test in 
Drosophila melanogaster. Environ Mutagen 1984, 
6:153-88 
16 Lasko D, Cavenee W. Loss of constitutional hetero- 
zygosity in human cancer. Annu Rev Genet 1991, 
25:281-314 
17 Frei H, Wfirgler FE. Statistical methods to decide 
whether mutagenicity est data from Drosophila ssays 
indicate a positive, negative, or inconclusive result. 
Murat Res 1988, 203:297-308 
18 Hall EJ. Radiobiology for the Radiologist, 4th edn. 
Philadelphia: J.B. Lippincott Company, 1994 
19 Schweizer P. Linear dose-response r lationship and 
no inverse dose-rate ffect observed for low X-ray 
dose-induced mitotic recombination in Drosophila 
melanogaster. Int J Radiat Biol 1995, 67:303-13 
20 Garcia-Bellido A, Merriam J. Parameters of wing 
imaginal disc development of Drosophila melanogaster. 
Development Biol 1971, 24:61-87 
21 Koechli OR, Schaerer GN, Schenk V, Haller U, Walt H. 
Assessment of effects of photosensitizers on cyto- 
toxicity and phtotodynamic therapy in human breast 
cancer cell cultures. Arch Gynecol Obstet 1995, 
256:167 6 
22 Dobler-Girdziunaite D, Burkard W, Haller U, Larsson 
B, Waet H. Kombinierte Anwendung der photo- 
dynamischen Therapie mit ionisierenden Strahlen bei 
Mammakarzinomzellen in vitro. Strahlenther Onkol 
1995, 171:622-9 
23 Vogel EM, Nivard JM. Performance of181 chemicals in 
a Drosophila assay predominantly monitoring intra- 
chromosomal mitotic recombination. Mutagenesis 1993, 
8:357-81 
Key words: Photodynamic therapy; Meso-tetra(hydroxy- 
phenyl) chlorin (mTHPC); Genotoxicity; SMART test; 
Drosophila melanogaster 
